What Should Directors Be Asking? Antitrust in the Boardroom
August 3, 2026
Competition law isn't just for antitrust lawyers anymore—it's increasingly a boardroom issue. What questions should directors be asking to ensure their companies are identifying and managing competition risk before it becomes a crisis?
Managing partner Jeny Maier and Anora Wang speak with Julie Goshorn, whose career spans the DOJ, FTC, private practice at Arnold & Porter, and global in-house leadership at Visa, about why corporate boards should view antitrust as an enterprise risk alongside cybersecurity, financial controls, and compliance. Listen to this episode to learn about the board’s oversight role, lessons from recent Delaware fiduciary duty cases, and the practical questions every director should be asking to help protect long-term enterprise value.
Watch below or on the Our Curious Amalgam website.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
Byline Articles
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials
American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives
Webinar
Antitrust
What's the Skinny on SCOTUS' Skinny Label Decision?
Webinar
Intellectual Property
National Bar Association Corporate Counsel Leadership Summit
Speaking Engagement
Antitrust
FTC Prescribes Lower Out-of-Pocket Insulin Costs in Settlement with Caremark
Axinn Viewpoints
Antitrust
The FTC’s Record $12 Million HSR Penalty: Deal Structuring, Avoidance, and the Line Between Them
Axinn Viewpoints
Antitrust
